Sopharma AD has reported the sale of 5,499 treasury shares on August 11, 2025. The transaction took place on the Bulgarian Stock Exchange, with an average price per share of BGN 2.46 and a total value of BGN 13,497.53.
Following this sale, Sopharma AD holds a total of 21,411,171 treasury shares. This represents approximately 3.97% of the company’s share capital.
The notification was made in accordance with Article 17 of Regulation (EU) No 596/2014 of the European Parliament and Council.
Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…
The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.
Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…
Sign-up for the Weekly Newsletter from EU Business Daily.